Can Oral Probiotics Support Your Child’s Ear–Throat Microbiome Connection?

Dr. Jamie Oskin, ND

Dr. Jamie Oskin, ND

Published March 27, 2026 10 min read

Can Oral Probiotics Support Your Child’s Ear–Throat Microbiome Connection?
💡

What You'll Learn in This Article

  • How your child's ears, nose, and throat form one connected microbial ecosystem.
  • What the Eustachian tube is and why it links the throat microbiome to the ear region.
  • What published pediatric studies — including a JAMA Network Open RCT — have explored about BLIS K12™ and ear-related wellness.
  • Why delivery format matters and how to use an oral probiotic for ENT support.

Most parents have heard a lot about the gut microbiome — the community of bacteria that lives in the digestive tract and plays a central role in overall wellness. And if you've been following Little Koala, you've also learned about the oral microbiome, and why what happens in your child's mouth matters far more than we used to think.

But here's a question that surprises a lot of parents: Did you know that your child's ear canal region has its own microbial community? And that it is connected — through anatomy and microbiology — to the very same oral and throat environment where beneficial bacteria like BLIS K12™ are active?*

In this post, I want to take you on a short tour of the ear-throat microbiome connection, highlight what researchers have explored about BLIS K12™ and ear-adjacent wellness, and help you understand how an oral probiotic can be part of a broader approach to supporting your child's overall ENT wellness conversation with their healthcare provider.*

The ENT System Is One Connected Ecosystem

Ear, nose, and throat — ENT — are not three separate systems. They are one interconnected ecosystem, sharing airway passages, mucous membranes, microbial communities, and immune-associated tissue. When we think about supporting any one part of this system, we need to think about the whole.

The ear canal and middle ear region are no exception. Like the mouth and throat, these areas are home to a diverse community of microorganisms. Research in the field of the microbiome has identified that a healthy, balanced microbial environment in the ear region — just like in the oral cavity — may play a role in supporting normal ear-related function and comfort.*

Understanding this connectivity changes how we think about supporting ENT wellness in children — and it opens the door to a conversation about oral probiotics that most parents have never had.

The Eustachian Tube: The Anatomical Bridge Between Throat and Ear

To understand why an oral probiotic like BLIS K12™ is relevant to ear-adjacent microbiome wellness, you need to know about a small but important anatomical structure: the Eustachian tube.*

The Eustachian tube is a narrow channel that runs from the back of the throat — right where your tonsils and adenoids are — up and into the middle ear. Its job is to help equalize pressure between the middle ear and the outside environment, and to allow normal fluid movement from the middle ear region.

Here is where it gets especially relevant for parents of young children: in children under about 7 years old, the Eustachian tube is shorter, flatter, and more horizontally oriented than in adults. This anatomical difference means that the microbial environment of the throat is more directly connected to the ear-adjacent region in young children than it is in adults.

"The Eustachian tube is the anatomical bridge between the oral-throat microbiome and the ear-adjacent region — which is why supporting the throat microbiome can be considered an upstream approach to ear-related microbiome wellness."*

This anatomical connection helps explain why ENT wellness considerations are so common in children. The anatomy makes the throat-to-ear relationship more direct. It also helps frame why researchers have been interested in BLIS K12™ when studying ENT and ear-related outcomes.*

What Is BLIS K12™ and Where Does It Work?

BLIS K12™ (Streptococcus salivarius K12) is a specific, research-studied strain of beneficial bacteria that is naturally found in the healthy human oral cavity. Unlike the gut-targeted probiotics you may be more familiar with, BLIS K12™ is considered an oral probiotic — it is designed to colonize the mouth and throat, not the digestive tract.*

BLIS K12™ colonizes the oral cavity and throat — the very area where the Eustachian tube openings are located. By helping support a healthy, balanced community of beneficial bacteria in the throat microbiome, BLIS K12™ works at the anatomical gateway between the throat and the middle ear region.*

How BLIS K12™ May Support Ear-Related Microbiome Wellness

Researchers have explored several mechanisms through which BLIS K12™ may support ear-adjacent microbiome wellness:*

  • Competitive colonization of the throat microbiome: BLIS K12™ helps establish a community of beneficial bacteria in the oral cavity and throat. This supports a healthy microbial balance at the Eustachian tube openings — the anatomical gateway to the middle ear region.*
  • Production of BLIS proteins: BLIS K12™ produces specialized compounds called Bacteriocin-Like Inhibitory Substances (BLIS) directly within the oral cavity and throat. Laboratory studies have shown that these proteins may help support a healthy microbial balance in the oral environment. (Note: this mechanism has been characterized in laboratory settings; clinical outcomes in children require separate evaluation.)*
  • Support for normal immune function in oral and upper respiratory tissues: BLIS K12™ interacts with the immune-associated tissues of the throat and upper respiratory tract, helping to support normal oral and upper respiratory wellness.*

What Researchers Have Explored About BLIS K12™ and Ear-Related Wellness

Science Education Note: The studies referenced in this section evaluated specific health endpoints in clinical settings. This educational summary does not constitute a disease prevention or treatment claim. Always consult your child's healthcare provider regarding any health concerns.

Multiple independent research teams — across different countries and study designs — have evaluated the relationship between BLIS K12™ supplementation and ENT- and ear-related wellness measures in children. The findings have been consistent enough to capture the attention of researchers publishing in major peer-reviewed journals.*

Pediatric Studies in Children Ages 3 and Older

A series of pediatric studies by Di Pierro and colleagues evaluated the effects of BLIS K12™ supplementation in children ages 3 and older. Across multiple study cohorts, researchers reported favorable measures of both throat-related wellness and ear-related wellness in children who used BLIS K12™, with some studies following participants for several months after the study period concluded.[1,2,3]*

These studies noted that the children who used BLIS K12™ experienced more positive ENT-related wellness measures compared to their own prior history or to untreated comparison groups — a pattern that aligns with the anatomical and microbiome science described above.*

A Randomized Controlled Trial in JAMA Network Open

A 2023 randomized controlled trial published in JAMA Network Open — a widely respected medical journal — evaluated Streptococcus salivarius K12 supplementation in children and assessed ear-related wellness outcomes. The researchers observed that children receiving S. salivarius K12 showed favorable ear-related wellness measures compared to those in the comparison group.[4]*

Publication in JAMA Network Open represents a meaningful level of scientific scrutiny for any research in children's wellness. The fact that this study was both randomized and controlled — considered a higher standard in clinical research — adds to the scientific literature exploring BLIS K12™ and ENT-related wellness in children.*

Which Children Might Be Candidates for a Conversation About Oral Probiotic Support?

Based on the research and my experience in pediatric naturopathic practice, certain children may be especially relevant candidates for a conversation with their healthcare provider about oral probiotic support for the oral-ear microbiome connection:

  • Young children ages 3 to 7: The Eustachian tube anatomy in this age group creates the most direct connection between the throat microbiome and the ear-adjacent region. This is a window when oral-to-ear microbiome connectivity is highest.
  • Children with a history of recurring ear-related wellness concerns: For children who have experienced frequent ear-area discomfort or ENT issues, supporting the throat microbiome proactively — rather than only reacting to problems — can be discussed as part of a broader wellness strategy.* Always discuss with your child's pediatrician or ENT specialist.
  • Children rebuilding microbiome balance after antibiotic use: Antibiotic courses can affect both the oral and gut microbiome. Children who have recently completed antibiotic treatment may benefit from talking with their healthcare provider about strategies — including probiotics — to support re-establishing a healthy oral microbiome balance.*
  • Children with a history of ear tube placement: Children who have had tympanostomy tubes placed may have ongoing Eustachian tube considerations that make proactive microbiome support particularly relevant to discuss with their otolaryngologist.

Delivery Format Matters: Why Chewable Lozenges Are Often the Preferred Choice

Not all probiotics are created equal — and delivery format makes a meaningful difference when the goal is oral and ear-adjacent microbiome support.

Gut-targeted probiotic capsules are swallowed and largely bypass the oral cavity. They can be excellent for gut health, but they are not designed to colonize the mouth and throat — which means they may not interact directly with the Eustachian tube openings or the throat microbiome where BLIS K12™ is intended to work.*

For oral and throat microbiome support related to the ENT system, a slow-dissolving chewable lozenge is often used. Allowing the lozenge to dissolve slowly in the mouth distributes BLIS K12™ across the oral and throat tissues, giving the probiotic strain the opportunity to colonize the areas where it has been studied.*

Practical guidance for use (educational, not individual medical advice):*

  • Take after evening tooth brushing to help create a favorable colonization environment
  • Allow the lozenge to dissolve slowly in the mouth — do not swallow whole
  • Avoid eating or drinking for at least 30 minutes after use
  • Many published studies have used consistent daily use for about 90 days, which is often referenced in research settings as a typical duration for microbiome-support protocols.*

A Word From Dr. Oskin: Please Partner With Your Healthcare Provider

I want to be clear about something important. While the research on BLIS K12™ and ENT-related wellness is genuinely compelling, oral probiotic support is a complementary wellness strategy — not a replacement for medical evaluation and care.

If your child is experiencing acute ear pain, fever, drainage from the ear, hearing changes, or any concerning symptoms, please seek prompt evaluation from your pediatrician or a pediatric ENT specialist. These symptoms require professional medical assessment.

Oral probiotic support for the oral-ear microbiome connection is best discussed as part of a proactive, ongoing wellness conversation with your child's healthcare team — not as a substitute for appropriate evaluation of acute symptoms. I encourage every parent reading this to bring what you've learned here to your next well-child visit and have that conversation.*

The Bottom Line: The Oral-Ear Microbiome Connection Is Real and Worth Exploring

The science connecting the oral microbiome to ENT- and ear-related wellness in children is grounded in anatomy — through the Eustachian tube — and supported by a growing body of peer-reviewed research, including a randomized controlled trial published in JAMA Network Open.*

BLIS K12™, as an oral probiotic strain that colonizes the throat at the anatomical gateway to the middle ear region, represents a thoughtful and research-informed way to support the oral and ENT-related microbiome in children.* If you are a parent who has been looking for a proactive, science-informed approach to your child's overall ENT wellness — this is a conversation worth having with your child's healthcare provider.*

Want to learn more about the oral-ear microbiome connection and oral probiotic science in children?
Explore Little Koala's formulations and research resources at getlittlekoala.com.

Note: The studies listed in this article were conducted on specific clinical health endpoints. Disease names appear in the original published citation titles. Their inclusion is for academic citation transparency only and does not constitute a disease treatment or prevention claim for any dietary supplement product.

Disclaimers

*These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

The information in this blog is for educational purposes only and does not constitute medical advice. Always consult your child's qualified healthcare provider before beginning any new supplement regimen or making changes to your child's healthcare routine. Seek prompt professional medical attention for any acute or concerning health symptoms.

Key Takeaways

  • The Eustachian tube connects the throat directly to the middle ear — especially in young children.
  • BLIS K12™ colonizes the throat at that anatomical gateway, supporting a balanced microbial environment upstream.
  • A slow-dissolving chewable lozenge delivers the probiotic where it's needed — gut capsules bypass the oral cavity entirely.

References

(1) Di Pierro F, Di Pasquale D, Di Cicco M. Oral use of Streptococcus salivarius K12 in children with secretory otitis media: preliminary results of a pilot, uncontrolled study. Int J Gen Med. 2015;8:303–308. doi:10.2147/IJGM.S92488
(2) Di Pierro F, Colombo M, Giuliani MG, et al. Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children. Eur Rev Med Pharmacol Sci. 2016;20(21):4601–4606.
(3) Di Pierro F, et al. Use of Streptococcus salivarius K12 to reduce the incidence of pharyngo-tonsillitis and acute otitis media in children: a retrospective analysis in not-recurrent pediatric subjects. Minerva Pediatr. 2018. doi:10.23736/S0026-4946.18.05182-4
(4) Sarlin S, Niskanen J, Koivisto M, et al. Streptococcus salivarius probiotics to prevent acute otitis media in children: a randomized clinical trial. JAMA Network Open. 2023;6(11):e2340608. doi:10.1001/jamanetworkopen.2023.40608
Dr. Jamie Oskin, ND

Dr. Jamie Oskin, ND

As a naturopathic doctor who has focused on children’s wellness for almost two decades, I created Little Koala to make my nutrition‑focused approach more accessible to families everywhere.

© 2026 Little Koala & Co. All rights reserved.
0:00